Table 1.

Ceftazidime–avibactam, imipenem–relebactam and meropenem–vaborbaktam in vitro activity against KPC-producing carbapenem-resistant Klebsiella pneumoniae.

Ceftazidime–Avibactam MIC [mg/L]	KPC (n)	Imipenem–Relebactam MIC [mg/L]	KPC (n)	Meropenem–Vaborbaktam MIC [mg/L]	KPC (n)
0.032	1	0.094	1	0.023	3
0.094	1	0.125	2	0.032	3
0.190	2	0.190	1	0.047	1
0.380	1	0.250	1
0.750	2	0.380	1
		0.5	1

MIC—minimal inhibitory concentration; KPC—Klebsiella pneumoniae carbapenemase.